id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0633-0002,FDA,FDA-2008-N-0633,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,N-Notice,2009-03-13T04:00:00Z,2009,3,2009-03-13T04:00:00Z,,2009-03-13T17:06:57Z,E9-05494,0,0,09000064809100cd
FDA-2008-N-0633-0001,FDA,FDA-2008-N-0633,Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Drug Experience Reporting,Notice,N-Notice,2008-12-16T05:00:00Z,2008,12,2008-12-16T05:00:00Z,2009-02-18T04:59:59Z,2008-12-20T16:20:56Z,E8-29664,0,0,09000064807dd800